Ikena Oncology, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Ikena Oncology, Inc. | IKNA - NASDAQ |
$15.00-$17.00 | $15.00 | $22.40 | 7.8 million | 3/26/2021 |
| Jefferies, Cowen, Credit Suisse, William Blair | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-03-04 Terms Added 2021-03-22 | ||||||
Ikena Oncology, Inc. Quote & Chart - Click for current quote - IKNA
IPO Boutique aggregates information on public companies and private companies, such as "IKNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Ikena Oncology, Inc. (adapted from Ikena Oncology, Inc. prospectus):
They are a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "IKNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.